<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthesia for emergency surgery after cardiac arrest
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthesia for emergency surgery after cardiac arrest
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthesia for emergency surgery after cardiac arrest
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nadia Blakemore Hensley, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles W Hogue, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Roberta Hines, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael F O'Connor, MD, FCCM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 26, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H138464732">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urgent or emergency surgery is sometimes necessary after cardiac arrest, despite an increased risk of perioperative morbidity or mortality. This topic reviews anesthetic considerations for patients who have suffered a recent cardiac arrest with successful resuscitation.
        </p>
        <p>
         Initial critical nonsurgical interventions for post-cardiac arrest patients are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient"
         </a>
         .)
        </p>
        <p>
         Anesthetic management of patients with persistent shock or cardiac arrest caused by traumatic injury is discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94581.html" rel="external">
          "Anesthesia for adult trauma patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104906569">
         <span class="h1">
          GENERAL CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who have experienced a recent cardiac arrest are at risk for cardiovascular collapse for several hours after resuscitation due to the sequelae of ischemic myocardial injury sustained during the arrest, as well as the underlying medical comorbidities that led to the arrest. Post-cardiac arrest syndrome may include myocardial dysfunction, dysrhythmias, brain injury, and systemic ischemia/reperfusion response [
         <a href="#rid1">
          1
         </a>
         ]. Persistent issues related to the precipitating pathology may include the cardiovascular system (eg, acute myocardial infarction, acute coronary syndrome, cardiomyopathy), thromboembolism (eg, pulmonary embolism), central nervous system morbidity (eg, stroke, encephalopathy), sequelae of severe pulmonary disease (eg, acute lung injury, chronic obstructive pulmonary disease, asthma), sepsis, hypovolemia, acute kidney injury, or drug toxicity due to overdose or poisoning [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Major problems and care priorities'
         </a>
         .)
        </p>
        <p>
         While not well studied, urgent surgery should not occur for at least 72 hours after a cardiac arrest to minimize the risk for additional myocardial, cerebral, renal, or pulmonary injury. However, emergency surgery may be necessary in selected patients. Types of surgery in which it might be necessary to proceed would include coronary artery bypass grafting for urgent revascularization, neurosurgery for significantly increased intracranial pressure due to tumor or bleeding, or thrombectomy for acute limb ischemia.
        </p>
        <p class="headingAnchor" id="H1577087041">
         <span class="h1">
          PREOPERATIVE EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to performing critical aspects of a standard preanesthesia evaluation as time allows, relevant imaging studies, such as a chest radiograph, computed tomography of the head or chest, or transesophageal or transthoracic echocardiography, should be reviewed prior to induction of anesthesia for an emergency procedure. Laboratory tests, such as hemoglobin, arterial blood gases, renal function, lactate, and tests of coagulation (see
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Tests of coagulation function'
         </a>
         ) are also examined once available, as these may be valuable to predict the need for blood component transfusion, guide management of intraoperative fluid administration and selection of anesthetic and neuromuscular blocking agents, as well as monitor the evolution of pathophysiologic processes that often occur after cardiac arrest.
        </p>
        <p>
         Details regarding the preanesthesia consultation are available in other topics. (See
         <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">
          "Preoperative evaluation for anesthesia for noncardiac surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94291.html" rel="external">
          "Preoperative evaluation for anesthesia for cardiac surgery"
         </a>
         .)
        </p>
        <p>
         Additional considerations before transport of critically ill patients are discussed in a separate topic  (
         <a class="graphic graphic_table graphicRef139204" href="/z/d/graphic/139204.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef139205" href="/z/d/graphic/139205.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">
          "Transport of surgical patients", section on 'Considerations for critically ill patients'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H620264431">
         <span class="h1">
          ANESTHETIC MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H361554410">
         <span class="h2">
          Intraoperative monitoring
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic monitors
         </strong>
         – Decisions regarding hemodynamic monitoring after recent cardiac arrest depends on patient-specific considerations (eg, hemodynamic stability, arrhythmia burden, persistent myocardial ischemia or dysfunction), as well as surgery-specific considerations (eg, anticipated blood loss or fluid shifts). An intra-arterial catheter for continuous blood pressure (BP) monitoring is present or inserted in most patients due to the need to control blood pressure, which often involves titration of vasoactive agents. (See
         <a class="local">
          'Blood pressure goals'
         </a>
         below and
         <a class="local">
          'Use of vasoactive agents'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Transesophageal echocardiography (TEE) may be employed to diagnose causes of persistent or severe intraoperative hemodynamic instability. (See
         <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">
          "Intraoperative rescue transesophageal echocardiography (TEE)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Discussion of monitoring considerations for unstable patients is available in another topic. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults", section on 'Intraoperative monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Since arrhythmias are common after cardiac arrest, we place transcutaneous pacing/defibrillator pads on the patient prior to induction of anesthesia in case defibrillation, cardioversion, or transcutaneous pacing may become necessary.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other monitors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Temperature
         </strong>
         – We monitor and manage temperature as noted below. (See
         <a class="local">
          'Temperature management'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Temperature monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Electroencephalography
         </strong>
         – Neuromonitors with raw or processed electroencephalography (EEG) are typically used after cardiac arrest to monitor for seizure activity. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Seizures and myoclonic jerks'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Also, burst suppression or EEG silence can be detected. Processed EEG may also be useful to ensure adequate anesthetic depth in patients who received a neuromuscular blocking agent (NMBA) since heart rate and blood pressure (BP) may be poor surrogates of anesthetic depth after cardiac arrest. (See
         <a class="medical medical_review" href="/z/d/html/400.html" rel="external">
          "Accidental awareness during general anesthesia", section on 'Brain monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Bladder catheter
         </strong>
         – Urine output (UO) is typically monitored using a bladder catheter. Although traditional targets that attempt to maintain UO &gt;0.5 mL/kg per hour do not predict acute kidney injury in critically ill patients [
         <a href="#rid2">
          2
         </a>
         ], more severe oliguria &lt;0.3 mL/kg per hour is avoided if possible [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Traditional static parameters'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3734569601">
         <span class="h2">
          Induction and maintenance of anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anesthetic goals are to produce unconsciousness, analgesia, muscle relaxation, and attenuation of the hemodynamic responses to intubation and surgical stimulation without compromising cerebral or myocardial blood flow.
        </p>
        <p>
         Most patients arrive in the operating room already intubated and sedated after suffering a cardiac arrest, and may not need an intravenous (IV) induction agent. For conscious patients with potential or actual hypotension, anesthetic induction agents with minimal hemodynamic effects are selected, as described in detail in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults", section on 'Induction'
         </a>
         .)
        </p>
        <p>
         Initiating or continuing low doses of opioid, sedative(s), and/or a volatile anesthetic agent will likely be necessary to maintain anesthesia during the procedure. In some cases, an NMBA may also be necessary to facilitate surgery. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview"
         </a>
         .)
        </p>
        <p>
         After a recent cardiac arrest, many patients have persistent myocardial ischemia or dysfunction which may lead to hypotension. Anesthetic management for these patients is discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/90616.html" rel="external">
          "Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'General anesthesia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/91654.html" rel="external">
          "Intraoperative management for noncardiac surgery in patients with heart failure", section on 'Management of general anesthesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1900006243">
         <span class="h2">
          Fluid management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fluid management depends on the cause of the recent cardiac arrest, the patient's current hemodynamic stability, and ongoing blood losses or fluid shifts during the surgical procedure. Administration of crystalloid fluid boluses (typically 250 to 500 mL per bolus) for hypovolemic conditions, or administration of blood products to treat anemia, severe or ongoing hemorrhage may be necessary. However, aggressive fluid resuscitation may have been performed during the cardiac arrest. In the post-arrest period, it is important to avoid over-resuscitation and maintain euvolemia. Excess fluid administration will worsen cardiac function in many patients such as those with cardiogenic shock with evidence of pulmonary edema or obstructive shock due to pulmonary embolism. Further discussions of monitoring intravascular volume status and treatment of derangements are available in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104907467">
         <span class="h2">
          Hemodynamic management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients presenting for emergency surgery shortly after cardiac arrest may require ongoing treatment to optimize BP and maintain end-organ perfusion (eg, boluses of IV fluid, blood transfusions, or vasopressors and/or inotropic drugs) [
         <a href="#rid4">
          4
         </a>
         ]. Specific interventions depend on the cause of arrest, although etiology may be complex or uncertain in patients presenting to the operating room for emergency surgery  (
         <a class="graphic graphic_table graphicRef99574" href="/z/d/graphic/99574.html" rel="external">
          table 3
         </a>
         ). Such post-arrest interventions may have been initiated in the emergency department or intensive care unit (ICU), in an attempt to prevent secondary injury from hypotension. Evaluation of hypotension occurring in the operating room with transesophageal echocardiography (TEE) is discussed in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef115554" href="/z/d/graphic/115554.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">
          "Intraoperative rescue transesophageal echocardiography (TEE)"
         </a>
         .).
        </p>
        <p>
         Further discussion of hemodynamic instability in these patients is available in other topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2732949699">
         <span class="h3">
          Blood pressure goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         During the perioperative period, we continue to maintain preoperative targeted mean arterial pressure (MAP) values, typically &gt;65 mmHg, in order to achieve optimal end-organ perfusion and reverse the acute shock state after initial resuscitation in patients with shock or cardiopulmonary arrest [
         <a href="#rid5">
          5
         </a>
         ]. However, the optimal BP target for end-organ perfusion is unclear and may vary among individual patients. For example, in patients who have not awakened in a timely manner or do not have an intact neurologic examination after cardiac arrest, the targeted MAP may have been increased to 80 to 100 mmHg to optimize cerebral perfusion since the upper and lower limits of cerebral autoregulation may be shifted upward [
         <a href="#rid6">
          6-8
         </a>
         ]. Episodes of hypotension are avoided, as these can cause secondary brain injury after cardiac arrest [
         <a href="#rid9">
          9-11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Maintaining end-organ perfusion'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient", section on 'Hemodynamic monitoring and goals'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4208421907">
         <span class="h3">
          Use of vasoactive agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         An intra-arterial catheter for continuous BP monitoring is necessary during titration of vasoactive agents, particularly if surgical interventions are ongoing.
        </p>
        <p>
         Continuous infusions of vasopressor agents are initiated if administration of IV fluids and reduction of anesthetic agent dosing fail to restore and maintain adequate BP and/or tissue perfusion. We prefer
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         as the first-line vasopressor when hypotension is present in post-cardiac arrest patients  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ), although there is no evidence demonstrating the superiority of infusion of any one vasopressor/inotropic agent in this setting [
         <a href="#rid12">
          12-14
         </a>
         ]. There is literature that suggests that norepinephrine is preferable to
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         or
         <a class="drug drug_general" data-topicid="9384" href="/z/d/drug information/9384.html" rel="external">
          dopamine
         </a>
         in similar situations [
         <a href="#rid13">
          13-15
         </a>
         ]. If persistent vasoplegia with low systemic vascular resistance is the likely cause of refractory shock, then a
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         infusion is added [
         <a href="#rid16">
          16
         </a>
         ]. In a 2018 meta-analysis of 23 trials (3088 patients) comparing use of catecholamines plus vasopressin versus catecholamines alone to treat patients with distributive shock, vasopressin was associated with lower risk for atrial fibrillation (risk ratio [RR] 0.77, 95% CI 0.67-0.88) and mortality (RR 0.89, 95% CI 0.82-0.97), and possibly lower risk of need for renal replacement therapy (RR 0.74, 95% CI 0.51-1.08) [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient", section on 'Hemodynamic monitoring and goals'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults"
         </a>
         .)
        </p>
        <p>
         Notably, transient global myocardial dysfunction (ie, myocardial stunning) is usually present immediately after cardiac arrest, although this often improves by approximately eight hours after arrest with return of left ventricular function to baseline by about 72 hours after cardiac arrest [
         <a href="#rid18">
          18
         </a>
         ]. The addition of an inotropic agent (eg,
         <a class="drug drug_general" data-topicid="9652" href="/z/d/drug information/9652.html" rel="external">
          milrinone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ) ) may be necessary in a patient with significant left or right ventricular failure if hemodynamic goals are not achieved with vasopressors and optimal preload  (
         <a class="graphic graphic_algorithm graphicRef120513" href="/z/d/graphic/120513.html" rel="external">
          algorithm 2
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef120514" href="/z/d/graphic/120514.html" rel="external">
          algorithm 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/91654.html" rel="external">
          "Intraoperative management for noncardiac surgery in patients with heart failure", section on 'Use of vasoactive and inotropic agents'
         </a>
         .)
        </p>
        <p>
         Myocardial dysfunction typically peaks during the first three days after cardiac arrest, and may be severe enough to cause cardiogenic shock [
         <a href="#rid1">
          1,4,18-20
         </a>
         ]. There may be evidence of global hypokinesis on TEE, or persistently low central venous oxygen saturation (S
         <sub>
          cv
         </sub>
         O
         <sub>
          2
         </sub>
         ) in blood drawn from the distal port of a central venous catheter (CVC) or low mixed venous oxygen saturation (S
         <sub>
          v
         </sub>
         O
         <sub>
          2
         </sub>
         )
         <sub>
         </sub>
         from the pulmonary arterial port of a pulmonary artery catheter (PAC) if a PAC is available [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">
          "Intraoperative rescue transesophageal echocardiography (TEE)", section on 'Cardiogenic shock'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1623.html" rel="external">
          "Oxygen delivery and consumption", section on 'Oxygen content'
         </a>
         .)
        </p>
        <p>
         Details regarding vasopressor and inotropic agents are available in other topics. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults", section on 'Cardiogenic shock management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/141346.html" rel="external">
          "Intraoperative use of vasoactive agents", section on 'Vasopressor and positive inotropic agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2947571463">
         <span class="h3">
          Other considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Factors that may adversely affect the myocardial oxygen demand/supply balance should be aggressively treated  (
         <a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">
          table 5
         </a>
         ), including tachycardia, hypotension, intravascular fluid overload, hypoxemia or hypocarbia, severe anemia, and unintentional hypothermia and shivering.
        </p>
        <p>
         Occasionally, a decision is made to insert a mechanical assist device in a patient with cardiogenic shock (eg, intra-aortic balloon pump, ventricular assist device) if there is inadequate response to inotropic support. (See
         <a class="medical medical_review" href="/z/d/html/83.html" rel="external">
          "Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1492.html" rel="external">
          "Short-term mechanical circulatory assist devices"
         </a>
         .)
        </p>
        <p>
         Rarely, extracorporeal membrane oxygenation may be used for a patient with refractory hypoxemia and/or severe ventricular dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Refractory pulseless ventricular tachycardia or ventricular fibrillation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H531542122">
         <span class="h2">
          Management of arrhythmias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Arrhythmias are common after cardiac arrest. Acute myocardial infarction, cardiomyopathy, and primary arrhythmias are the most common causes of cardiac arrest. Any underlying causes of arrhythmias are corrected during the perioperative period if possible (eg, acute myocardial ischemia  (
         <a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">
          table 5
         </a>
         )), electrolyte imbalances.
        </p>
        <p>
         Fluctuations in serum potassium may occur during and after cardiac arrest as a result of ischemia, acidosis, and catecholamine administration. Both high and low potassium levels can cause arrhythmias and should be corrected. The most common causes of hyperkalemia are renal insufficiency/failure and drugs that inhibit the renin-angiotensin-aldosterone system. Hypokalemia is often accompanied by hypomagnesemia, which should also be corrected (see
         <a class="medical medical_review" href="/z/d/html/2294.html" rel="external">
          "Bicarbonate therapy in lactic acidosis"
         </a>
         ). Thus, potassium levels and acid-base status, as well as serum levels of magnesium, calcium, and sodium should all be checked in any patient with persistent post-arrest arrhythmias. (See
         <a class="medical medical_review" href="/z/d/html/118690.html" rel="external">
          "Intraoperative advanced cardiac life support (ACLS)", section on 'Electrolyte abnormalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Electrolyte abnormalities'
         </a>
         .)
        </p>
        <p>
         No data support the routine or prophylactic use of antiarrhythmic drugs after the return of spontaneous circulation following cardiac arrest, even if such medications were employed during resuscitation. Antiarrhythmic drugs should be reserved for patients with recurrent or ongoing unstable arrhythmias. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Preventing arrhythmia'
         </a>
         .)
        </p>
        <p>
         Management of specific cardiac arrhythmias during anesthesia or in the perioperative period is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Management of specific arrhythmias'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104907473">
         <span class="h2">
          Respiratory management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of mechanical ventilation balances the need to reverse hypoxemia and acidosis in the post-arrest patient with the potentially deleterious effects of hyperventilation or hyperoxia. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Respiratory considerations'
         </a>
         .)
        </p>
        <p>
         For patients already receiving mechanical ventilation, preoperative mechanical ventilation settings are generally replicated in the operating room. As with all critically ill patients undergoing general anesthesia, we employ a lung-protective ventilation strategy (see
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">
          "Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Low tidal volume ventilation: Initial settings'
         </a>
         ):
        </p>
        <p>
         Specific considerations for mechanical ventilation after cardiac arrest include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use low tidal volumes of 6 to 8 mL/kg predicted body weight
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Avoid hyperoxia (defined as partial pressure of oxygen [PaO
         <sub>
          2
         </sub>
         ] &gt;300 mmHg), which may be associated with increased in-patient mortality in patients with return of spontaneous circulation following cardiac arrest [
         <a href="#rid22">
          22-24
         </a>
         ]. We adjust the fraction of inspired O
         <sub>
          2
         </sub>
         (FiO
         <sub>
          2
         </sub>
         ) to maintain peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) at approximately 94 percent and/or PaO
         <sub>
          2
         </sub>
         at approximately 70 to 80 mmHg. Supporting data, limitations, and controversies surrounding this approach are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Respiratory considerations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Set the respiratory rate to maintain the partial pressure of carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) at 40 to 45 mmHg (with end-tidal CO
         <sub>
          2
         </sub>
         at 35 to 40 mmHg) to prevent hypocapnia-induced cerebral vasoconstriction. It is unknown whether higher PaCO
         <sub>
          2
         </sub>
         levels might contribute to vasodilation, hyperemia, or cerebral edema after cardiac arrest. Thus, only mild permissive hypercapnia is allowed (ie, PaCO
         <sub>
          2
         </sub>
         40 to 45 mmHg). In patients with metabolic acidosis or known or suspected increased intracranial pressure, a lower target for PaCO
         <sub>
          2
         </sub>
         may be selected (ie, approximately 35 mmHg). More aggressive hyperventilation is avoided because this increases cerebral vasoconstriction and reduces cardiac output by decreasing preload [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients already receiving mechanical ventilation, use the positive end-expiratory pressure (PEEP) that was used in the ICU. For recently intubated patients, use an initial PEEP setting at 0 cm H
         <sub>
          2
         </sub>
         O until adequate resuscitation and hemodynamic stability are ensured. Subsequently, PEEP may be slowly and incrementally increased to 5 cm H
         <sub>
          2
         </sub>
         O if tolerated without provoking hypotension. The goal is to provide an optimal balance between minimizing lung injury and preventing hemodynamic instability. It is particularly important to avoid high levels of PEEP or dynamic hyperinflation with consequent development of auto-PEEP because high PEEP levels increase intrathoracic pressure and decrease venous return, cardiac output, and MAP. Decreasing or discontinuing PEEP and adjusting the ventilator settings to decrease mean airway pressure may improve venous return to the heart and improve these hemodynamic parameters. Furthermore, high PEEP levels may reduce cerebral perfusion pressure and should be modified in patients with suspected or known elevated intracranial pressure (ICP) [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">
          "Clinical and physiologic complications of mechanical ventilation: Overview", section on 'Hypotension'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients receiving
         <a class="drug drug_general" data-topicid="9447" href="/z/d/drug information/9447.html" rel="external">
          inhaled nitric oxide
         </a>
         or inhaled
         <a class="drug drug_general" data-topicid="9411" href="/z/d/drug information/9411.html" rel="external">
          epoprostenol
         </a>
         for hypoxemia, pulmonary hypertension, or right ventricular failure, avoid interruption of this inhaled therapy throughout the perioperative period. (See
         <a class="medical medical_review" href="/z/d/html/8264.html" rel="external">
          "Inhaled nitric oxide in adults: Biology and indications for use"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2137144702">
         <span class="h2">
          Temperature management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative normothermia of 36°C is the goal for temperature management in most patients after cardiac arrest. Hyperthermia must be avoided in all patients after cardiac arrest. Fever is associated with worse neurologic outcomes, presumably due to aggravation of secondary brain injury.
        </p>
        <p>
         Selected patients may have had mild hypothermia (typically with a target of 36°C) induced in the preoperative period, which is usually maintained for approximately 24 hours. Examples include those with moderate coma (not following commands but with some motor response), no evidence of seizure activity on their electroencephalogram, and no evidence of cerebral edema on computed tomography scan. This therapy is discussed in detail in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Temperature management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient", section on 'Active temperature control'
         </a>
         .)
        </p>
        <p>
         Perioperative temperature management is described in detail in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104907479">
         <span class="h2">
          Glycemic control
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serum glucose should be maintained between 140 and 180 mg/dL (7.8 and 10 mmol/L) during the period following cardiac arrest. Hypoglycemic episodes are carefully avoided. In critically ill patients, there is no benefit and possible harm from intensive control of the serum glucose (70 to 108 mg/dL [3.9 to 6 mmol/L]) compared with more liberal management (108 to 144 mg/dL [6 to 8.1 mmol/L]) [
         <a href="#rid27">
          27-30
         </a>
         ]. However, hyperglycemia is also avoided, as this has been associated with worse outcomes in post-cardiac arrest patients, presumably due to aggravation of secondary brain injury [
         <a href="#rid31">
          31-33
         </a>
         ]. Possible mechanisms include increased tissue acidosis from anaerobic metabolism, free radical generation, and increased blood-brain barrier permeability. (See
         <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">
          "Glycemic control in critically ill adult and pediatric patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Glycemic control'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H403806723">
         <span class="h1">
          IMMEDIATE POSTOPERATIVE MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postoperative intensive care is usually planned for patients who have suffered a recent cardiac arrest and resuscitation. Considerations for transport to the intensive care unit (ICU)  (
         <a class="graphic graphic_table graphicRef139204" href="/z/d/graphic/139204.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef139205" href="/z/d/graphic/139205.html" rel="external">
          table 2
         </a>
         ), and handoff to ICU personnel  (
         <a class="graphic graphic_table graphicRef94973" href="/z/d/graphic/94973.html" rel="external">
          table 6
         </a>
         ), are discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">
          "Transport of surgical patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94586.html" rel="external">
          "Handoffs of surgical patients"
         </a>
         .)
        </p>
        <p>
         Considerations for further management in the ICU are discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/127223.html" rel="external">
          "Intensive care unit management of the intubated post-cardiac arrest adult patient"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1238060874">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117075.html" rel="external">
          "Society guideline links: Basic and advanced cardiac life support in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104908099">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General considerations –
         </strong>
         Patients who have experienced a recent cardiac arrest are at risk for cardiovascular collapse for several hours after resuscitation due to the sequelae of ischemic myocardial injury sustained during the arrest, as well as the underlying medical comorbidities that led to the arrest. Ideally, urgent surgery should not occur for at least 72 hours after a cardiac arrest to minimize risk for additional myocardial, cerebral, renal, or pulmonary injury. However, emergency surgery may be necessary in selected patients. Considerations before transport of critically ill patients are noted in the tables  (
         <a class="graphic graphic_table graphicRef139204" href="/z/d/graphic/139204.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef139205" href="/z/d/graphic/139205.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">
          "Transport of surgical patients", section on 'Considerations for critically ill patients'
         </a>
         and
         <a class="local">
          'General considerations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring –
         </strong>
         Decisions regarding hemodynamic monitoring after recent cardiac arrest depends on patient-specific considerations (eg, hemodynamic stability, persistent myocardial ischemia or dysfunction), as well as surgery-specific considerations (eg, anticipated blood loss or fluid shifts). Evaluation of intraoperative hypotension with transesophageal echocardiography (TEE) is discussed in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef115554" href="/z/d/graphic/115554.html" rel="external">
          algorithm 1
         </a>
         ). In addition, temperature and urine output are monitored, and raw or processed electroencephalography (EEG) is often employed to monitor for post-arrest seizure activity. (See
         <a class="local">
          'Intraoperative monitoring'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of arrhythmias –
         </strong>
         Since arrhythmias are common after cardiac arrest, we place transcutaneous pacing/defibrillator pads on the patient prior to induction of anesthesia in case defibrillation, cardioversion, or transcutaneous pacing may become necessary. Any underlying causes of arrhythmias are corrected (eg, acute myocardial ischemia  (
         <a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">
          table 5
         </a>
         ), electrolyte abnormalities). Antiarrhythmic drugs should be reserved for patients with recurrent or ongoing unstable arrhythmias. (See
         <a class="local">
          'Management of arrhythmias'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic management –
         </strong>
         Patients who arrive in the operating room already intubated and sedated generally do not need an intravenous (IV) induction agent. For conscious patients who are hypotensive, anesthetic induction and maintenance agents with minimal hemodynamic effects are selected. Initiating or continuing low doses of opioid, sedative(s), and/or a volatile anesthetic agent will likely be necessary to maintain anesthesia during the procedure. In some cases, a neuromuscular blocking agent (NMBA) may also facilitate surgery. (See
         <a class="local">
          'Induction and maintenance of anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid management –
         </strong>
         Fluid management depends on the cause of the recent cardiac arrest, the patient's current hemodynamic stability, and ongoing blood losses or fluid shifts during the surgical procedure. Administration of crystalloid fluid boluses (typically 250 to 500 mL per bolus) for hypovolemic conditions, or administration of blood products to treat severe or ongoing hemorrhage may be necessary. However, it is important to avoid over-resuscitation and maintain euvolemia. Excess fluid administration worsens cardiac function in many patients (eg, those with cardiogenic shock). (See
         <a class="local">
          'Fluid management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Blood pressure goals –
         </strong>
         We suggest maintaining preoperative targeted mean arterial pressure (MAP) values, typically &gt;65 mmHg (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). This threshold prioritizes achieving optimal end-organ perfusion and reversing the acute shock state after initial resuscitation in patients with shock or cardiopulmonary arrest. However, in patients who have not awakened or do not have an intact neurologic examination, the targeted perioperative MAP may be maintained higher (eg, 80 to 100 mmHg) since the upper and lower limits of cerebral autoregulation may be shifted upward. Episodes of hypotension are avoided, as these can cause secondary injury. (See
         <a class="local">
          'Blood pressure goals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Use of vasoactive agents –
         </strong>
         We suggest
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         as the first-line vasopressor to treat hypotension  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). For patients with persistent vasoplegia with low systemic vascular resistance is the likely cause of refractory shock, we suggest addition of a
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         infusion (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Addition of an inotropic agent (eg,
         <a class="drug drug_general" data-topicid="9652" href="/z/d/drug information/9652.html" rel="external">
          milrinone
         </a>
         ) may be necessary in patients with significant left or right ventricular failure if hemodynamic goals are not achieved with vasopressors and optimal preload  (
         <a class="graphic graphic_algorithm graphicRef120513" href="/z/d/graphic/120513.html" rel="external">
          algorithm 2
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef120514" href="/z/d/graphic/120514.html" rel="external">
          algorithm 3
         </a>
         ). An intra-arterial catheter for continuous blood pressure (BP) monitoring is necessary during titration of vasoactive agents. (See
         <a class="local">
          'Use of vasoactive agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of ventilation –
         </strong>
         Management of mechanical ventilation balances the need to reverse hypoxemia and acidosis in the post-arrest patient with the potentially deleterious effects of hyperventilation or hyperoxia. As with all critically ill patients undergoing general anesthesia, we employ a lung-protective ventilation strategy, and we usually adjust the fraction of inspired O
         <sub>
          2
         </sub>
         (FiO
         <sub>
          2
         </sub>
         ) to approximately maintain peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) at 94 percent and/or the partial pressure of oxygen (PaO
         <sub>
          2
         </sub>
         ) at 100 mmHg, with the respiratory rate set to maintain the partial pressure of carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) at 40 to 45 mmHg. (See
         <a class="local">
          'Respiratory management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Temperature management –
         </strong>
         Intraoperative normothermia is the goal for temperature management in most patients after cardiac arrest. Selected patients may have had mild hypothermia induced in the preoperative period (typically with a target of 36°C), usually to be maintained for approximately 24 hours. Hyperthermia must be avoided in all patients after cardiac arrest (See
         <a class="local">
          'Temperature management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glycemic control –
         </strong>
         We suggest that serum glucose be monitored and maintained between 140 and 180 mg/dL (7.8 and 10 mmol/L) during the period following cardiac arrest (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Both
         <strong>
          hyper
         </strong>
         glycemia and
         <strong>
          hypo
         </strong>
         glycemic episodes are carefully avoided. (See
         <a class="local">
          'Glycemic control'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transport and handoff to intensive care unit (ICU) personnel –
         </strong>
         Considerations for postoperative transport to the ICU  (
         <a class="graphic graphic_table graphicRef139204" href="/z/d/graphic/139204.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef139205" href="/z/d/graphic/139205.html" rel="external">
          table 2
         </a>
         ), and handoff to ICU personnel  (
         <a class="graphic graphic_table graphicRef94973" href="/z/d/graphic/94973.html" rel="external">
          table 6
         </a>
         ), are discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">
          "Transport of surgical patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94586.html" rel="external">
          "Handoffs of surgical patients"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118:2452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egal M, Erler NS, de Geus HR, et al. Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis. Anesth Analg 2016; 122:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kunst G, Ostermann M. Intraoperative permissive oliguria - how much is too much? Br J Anaesth 2017; 119:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pellis T, Sanfilippo F, Ristagno G. The optimal hemodynamics management of post-cardiac arrest shock. Best Pract Res Clin Anaesthesiol 2015; 29:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rochwerg B, Hylands M, Møller MH, et al. CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock. Intensive Care Med 2017; 43:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beylin ME, Perman SM, Abella BS, et al. Higher mean arterial pressure with or without vasoactive agents is associated with increased survival and better neurological outcomes in comatose survivors of cardiac arrest. Intensive Care Med 2013; 39:1981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaieski DF, Band RA, Abella BS, et al. Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation 2009; 80:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sekhon MS, Gooderham P, Menon DK, et al. The Burden of Brain Hypoxia and Optimal Mean Arterial Pressure in Patients With Hypoxic Ischemic Brain Injury After Cardiac Arrest. Crit Care Med 2019; 47:960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trzeciak S, Jones AE, Kilgannon JH, et al. Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med 2009; 37:2895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray JE, Bernard S, Cantwell K, et al. The association between systolic blood pressure on arrival at hospital and outcome in adults surviving from out-of-hospital cardiac arrests of presumed cardiac aetiology. Resuscitation 2014; 85:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilgannon JH, Roberts BW, Reihl LR, et al. Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. Resuscitation 2008; 79:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gamper G, Havel C, Arrich J, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2016; 2:CD003709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy B, Clere-Jehl R, Legras A, et al. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 2018; 72:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bougouin W, Slimani K, Renaudier M, et al. Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med 2022; 48:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ukor IF, Walley KR. Vasopressin in Vasodilatory Shock. Crit Care Clin 2019; 35:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McIntyre WF, Um KJ, Alhazzani W, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA 2018; 319:1889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40:2110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peberdy MA, Callaway CW, Neumar RW, et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stub D, Bernard S, Duffy SJ, Kaye DM. Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation 2011; 123:1428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sander M, Spies CD, Foer A, et al. Agreement of central venous saturation and mixed venous saturation in cardiac surgery patients. Intensive Care Med 2007; 33:1719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts BW, Kilgannon JH, Hunter BR, et al. Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study. Circulation 2018; 137:2114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vincent JL, Taccone FS, He X. Harmful Effects of Hyperoxia in Postcardiac Arrest, Sepsis, Traumatic Brain Injury, or Stroke: The Importance of Individualized Oxygen Therapy in Critically Ill Patients. Can Respir J 2017; 2017:2834956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang CH, Chang WT, Huang CH, et al. The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies. Resuscitation 2014; 85:1142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation. Crit Care Med 2004; 32:S345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herff H, Paal P, von Goedecke A, et al. Influence of ventilation strategies on survival in severe controlled hemorrhagic shock. Crit Care Med 2008; 36:2613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, Finfer S, Chittock D, et al. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med 2015; 41:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luethi N, Cioccari L, Eastwood G, et al. Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol. Acta Anaesthesiol Scand 2019; 63:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med 2012; 23:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longstreth WT Jr, Diehr P, Cobb LA, et al. Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation. Neurology 1986; 36:1186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin J, Kim K, Lim YS, et al. Incidence and clinical features of intracranial hemorrhage causing out-of-hospital cardiac arrest: a multicenter retrospective study. Am J Emerg Med 2016; 34:2326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borgquist O, Wise MP, Nielsen N, et al. Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C. Crit Care Med 2017; 45:1337.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 93789 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18948368" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26505575" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29156029" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Intraoperative permissive oliguria - how much is too much?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26670819" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The optimal hemodynamics management of post-cardiac arrest shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28497273" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23995983" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Higher mean arterial pressure with or without vasoactive agents is associated with increased survival and better neurological outcomes in comatose survivors of cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19217200" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30889022" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The Burden of Brain Hypoxia and Optimal Mean Arterial Pressure in Patients With Hypoxic Ischemic Brain Injury After Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19866506" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Significance of arterial hypotension after resuscitation from cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24333351" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The association between systolic blood pressure on arrival at hospital and outcome in adults surviving from out-of-hospital cardiac arrests of presumed cardiac aetiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18990478" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26878401" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Vasopressors for hypotensive shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20200382" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Comparison of dopamine and norepinephrine in the treatment of shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29976291" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35129643" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30784607" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Vasopressin in Vasodilatory Shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29801010" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12505221" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20956225" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21464058" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Post cardiac arrest syndrome: a review of therapeutic strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17525841" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Agreement of central venous saturation and mixed venous saturation in cardiac surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29437118" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28246487" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Harmful Effects of Hyperoxia in Postcardiac Arrest, Sepsis, Traumatic Brain Injury, or Stroke: The Importance of Individualized Oxygen Therapy in Critically Ill Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24892265" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15508657" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18679111" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Influence of ventilation strategies on survival in severe controlled hemorrhagic shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318384" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Intensive versus conventional glucose control in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26088909" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30882892" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22863436" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3748384" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27727067" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Incidence and clinical features of intracranial hemorrhage causing out-of-hospital cardiac arrest: a multicenter retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28708678" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
